Navigation Links
Cynosure Receives Additional International Regulatory Approvals for New Cellulite Reduction Workstations
Date:5/17/2011

WESTFORD, Mass., May 17, 2011 /PRNewswire/ -- Cynosure, Inc. (Nasdaq: CYNO), a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced the receipt of two additional international clearances for the Company's new flagship workstations for cellulite reduction.

Cynosure has received regulatory clearance from Australia's Therapeutic Goods Administration (TGA) for its Cellulaze™ Cellulite Laser Workstation, the world's first minimally invasive surgical device for the long-term reduction of cellulite.  The Company also has obtained approval to market its SmoothShapes XV, a non-invasive system for the temporary reduction in the appearance of cellulite, from the Taiwan Food and Drug Administration (TFDA).  Cynosure plans to sell these products through its independent distributors in each country.

"Australia and the Asia Pacific are important and attractive markets for Cynosure as we focus on expanding the international reach of our newest products, particularly our cellulite platform," said President and Chief Executive Officer Michael Davin.  "Consumer demand for aesthetic procedures in these countries is strong, and practitioners are eager to integrate new technologies capable of providing safe, efficacious treatments that result in high levels of patient satisfaction.  We are encouraged about the prospects for Cellulaze and SmoothShapes XV as we grow their distribution channels and build global product recognition."

Cellulaze and SmoothShapes XV have received CE Mark certification in the European Union. SmoothShapes XV also is cleared for marketing in the United States.

Cellulaze, which uses laser thermal energy to target cellulite beneath the surface of the skin, is designed to restore the skin's normal structure and underlying connective tissue. A recently presented clinical study demonstrated the potential of Cellulaze's minimally invasive, sidelight three-dimensional optical fiber and 1440 nm Nd:YAG laser in delivering long-lasting benefits for the treatment of cellulite.  The condition is marked by dimply herniations and depressions within the layers of the skin, typically on the waist, buttocks and thighs.  Cellulite affects an estimated 85 percent of women over age 20(1).

The SmoothShapes XV system treats cellulite through a proprietary process known as Photomology®, which combines laser and light energy with mechanical manipulation (vacuum and massage) to produce tighter, smoother-looking skin.

About Cynosure, Inc.

Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis and reduce the appearance of cellulite.  Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulse dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991.  For corporate or product information, contact Cynosure at 800-886-2966, or visit www.cynosure.com.

Forward-Looking Statements

Any statements in this press release about future expectations, plans and prospects for Cynosure, Inc., as well as other statements containing the words "believes," "anticipates," "plans," "expects," "will" and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995.  Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including the global economy and lending environment and their effects on the aesthetic laser industry, Cynosure's history of operating losses, its reliance on sole source suppliers, the inability to accurately predict the timing or outcome of regulatory decisions, changes in consumer preferences, competition in the aesthetic laser industry, economic, market, technological and other factors discussed in Cynosure's most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, which are filed with the Securities and Exchange Commission.  In addition, the forward-looking statements included in this press release represent Cynosure's views as of the date of this press release.  Cynosure anticipates that subsequent events and developments will cause its views to change.  However, while Cynosure may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so.  These forward-looking statements should not be relied upon as representing Cynosure's views as of any date subsequent to the date of this press release.

(1) Rawlings, A.V. Cellulite and its treatment. Int. J. Cosmet. Sci. 28, 175–190 (2006).

Contact:

Scott Solomon
Vice President
Sharon Merrill Associates, Inc.
Phone: (617) 542-5300
cyno@investorrelations.com


'/>"/>
SOURCE Cynosure, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation
2. Cynosure Announces Presentation of Favorable Results from Post-Marketing Studies of Smartlipo MPX
3. Cynosure to Announce Third-Quarter 2009 Financial Results on October 27
4. Romeo and Juliette Laser Hair Removal Is First Center in New York City to Own Cynosures New Elite MPX(TM) Laser System
5. Cynosure to Present at UBS Global Life Sciences Conference
6. Cynosure to Host Third-Quarter 2010 Financial Results Conference Call on October 26
7. Cynosure to Present at 4th Annual Maxim Group Growth Conference
8. Cynosure Introduces Cellulaze, the Worlds First Aesthetic Laser Device for the Long-Term Reduction of Cellulite
9. Cynosure Receives International Marketing Clearances for New Cellulite, Laser Lipolysis Products
10. Cynosure to Present at 10th Annual Needham Healthcare Conference
11. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Inc ., a digital health company focused on modernizing and ... $25 million in Series B funding led by Qiming US ... Seattle that is part of a broader family ... included participation from SR One , who led ZappRx,s ... Google Ventures). As part of the financing, Mark McDade ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
(Date:4/19/2017)... The Mobile X-Ray product segment is the most ... the forecast period Mobile X-Ray segment is the ... X-Ray devices market, which is estimated to be valued at ... CAGR of 7% over the forecast period. Mobile X-Ray segment ... US$ 100 Mn in 2017 over 2016. The segment,s revenue ...
Breaking Medicine Technology:
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... ... professor Christopher Salas-Wright finds that youth violence is declining—and at noteworthy rates. Between ... relative proportion of young people involved in violence in the United States. The ...
(Date:4/21/2017)... ... ... Dudnyk has announced the launch of its new brand identity, called The Unifying ... and orphan brands can only be achieved when the needs and beliefs of patients ... the heart of a true partnership between our agency and our clients to unite ...
(Date:4/21/2017)... ... 2017 , ... Crossover Symmetry , an evidence based ... lifestyle company that provides Human Performance Training and education to tactical athletes. Together ... military officers and others in service through the development and conditioning of overall ...
(Date:4/21/2017)... Malvern, Worcestershire, UK (PRWEB) , ... April 21, ... ... Queen’s Award for Enterprise in the category of International Trade, the UK’s most ... performance in international trade, which represents 95% of total revenues and has grown ...
(Date:4/21/2017)... ... ... Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, wrote an open ... with solution to peace plan. Yisrayl says war has never brought peace and he knows ... Creator Himself. , Yisrayl says war drums are beating all over the media and ...
Breaking Medicine News(10 mins):